Ethnopharmacological relevance: Coptis chinensis Franch. (Huanglian), widely recognized as a representative heat‑clearing herb in traditional Chinese medicine (TCM), is commonly used in the clinical management of type 2 diabetes mellitus (T2DM) in China. Palmatine (PL), a major isoquinoline alkaloid isolated from Huanglian, exhibits anti-hyperglycemic potential, but its target and underlying mechanism remain to be fully elucidated. Aim of the study: Mitochondrial dysfunction and the resultant reactive oxygen species (ROS)-mediated insulin resistance (IR) are key drivers of T2DM progression. This study aimed to explore the therapeutic potential of PL against T2DM and its mechanism of action in restoring mitochondrial function and alleviating IR.Materials and methods: An integrated strategy of thermal proteome profiling (TPP) and network pharmacology was employed to identify the potential antidiabetic targets of PL. The regulatory effects of PL on mitochondrial function and energy metabolism, ROS production, and the AMP-activated protein kinase (AMPK) signaling pathway were assessed in vitro. NDUFV1-knockdown HepG2 cells were constructed to investigate the role of NDUFV1 in PL‑mediated regulation of glycolipid metabolism. A T2DM mouse model induced by a high‑fat diet (HFD) combined with streptozotocin (STZ) injection was established. The protective effects and underlying mechanism of PL were systematically evaluated using insulin metabolism parameter measurements, glucose tolerance tests (GTT), insulin tolerance tests (ITT), hepatic H&E staining, Oil Red O staining, biochemical and oxidative stress marker analysis, and Western blotting.Results: NADH dehydrogenase ubiquinone flavoprotein 1 (NDUFV1) served as a primary target of PL in regulating glycolipid metabolism. By directly binding to NDUFV1, PL inhibited the mitochondrial electron transport chain (ETC) activity, reduces excessive glucose and lipid-induced ROS accumulation, and restores AMPK signaling, which subsequently enhances glycolysis, glucose uptake, and glycogen synthesis while suppressing lipogenesis. Furthermore, PL attenuated the diabetic phenotype, dyslipidemia, and liver injury by targeting hepatic NDUFV1 to regulate the ROS/AMPK pathway in T2DM mice.Conclusion: PL targets NDUFV1 to inhibit ETC function and regulate the ROS/AMPK pathway, thereby alleviating glycolipid metabolic disorders and IR in T2DM.